Amylyx Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 16.73 M | $300.43 M | 0.59% | 15.04% |
| BLACKROCK, INC. | 08/07/2026 | 8.83 M | $158.53 M | -0.02% | 7.94% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 8.33 M | $149.69 M | 0.60% | 7.50% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 6.24 M | $112.14 M | 0.00% | 5.62% |
| COMMODORE CAPITAL LP | 08/14/2026 | 5.65 M | $101.47 M | 0.00% | 5.08% |
| JUPITER TOPCO LLC | 08/14/2026 | 5.24 M | $94.01 M | 100.00% | 4.71% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2026 | 4.62 M | $83.05 M | 6.30% | 4.16% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.22 M | $75.87 M | 2.00% | 3.80% |
| MORGAN STANLEY | 08/13/2026 | 3.13 M | $56.23 M | 43.91% | 2.82% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.04 M | $54.54 M | 1.67% | 2.73% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2026 | 3.02 M | $54.30 M | -5.25% | 2.72% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 2.95 M | $52.99 M | 30.45% | 2.65% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.86 M | $51.33 M | 8.84% | 2.57% |
| STATE STREET CORP | 09/22/2026 | 2.60 M | $46.76 M | 10.16% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.34 M | $41.95 M | 5.63% | 2.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 1.90 M | $34.12 M | -46.64% | 1.71% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.86 M | $34.92 M | 1,067.24% | 1.68% |
| SIREN, L.L.C. | 08/13/2026 | 1.48 M | $26.59 M | 20.37% | 1.33% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 1.33 M | $23.84 M | -12.31% | 1.19% |
| 683 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.28 M | $22.98 M | -16.37% | 1.15% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.06 M | $19.07 M | 12.36% | 0.95% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 1.05 M | $18.91 M | 100.00% | 0.95% |
| ALMITAS CAPITAL LLC | 08/17/2026 | 974.88 K | $17.51 M | -54.07% | 0.88% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 902.46 K | $16.22 M | -0.08% | 0.81% |
| JONES HILL CAPITAL LP | 08/13/2026 | 894.06 K | $16.06 M | -44.08% | 0.80% |
| WOODLINE PARTNERS LP | 08/14/2026 | 846.39 K | $15.20 M | 0.07% | 0.76% |
| NORTHERN TRUST CORP | 08/13/2026 | 831.74 K | $14.94 M | 6.65% | 0.75% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 821.84 K | $14.76 M | -38.24% | 0.74% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 800.00 K | $14.37 M | 0.00% | 0.72% |
| ABRDN PLC | 07/31/2026 | 737.67 K | $13.25 M | 100.00% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 725.03 K | $13.02 M | 1.23% | 0.65% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 725.03 K | $13.02 M | 100.00% | 0.65% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 721.00 K | $12.95 M | -16.97% | 0.65% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 700.00 K | $12.57 M | -60.00% | 0.63% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 684.97 K | $12.30 M | -38.14% | 0.62% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 681.39 K | $12.24 M | -2.97% | 0.61% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 623.08 K | $11.19 M | 6.30% | 0.56% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 593.44 K | $10.66 M | 266.44% | 0.53% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 557.94 K | $10.02 M | -55.99% | 0.50% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 499.76 K | $8.98 M | 0.00% | 0.45% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 494.38 K | $8.88 M | -50.59% | 0.44% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 486.68 K | $8.74 M | -9.15% | 0.44% |
| FEDERATED HERMES, INC. | 08/12/2026 | 462.21 K | $8.30 M | 27.14% | 0.42% |
| NEARWATER CAPITAL MARKETS, LTD | 08/14/2026 | 425.00 K | $7.63 M | 100.00% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 405.30 K | $7.28 M | 59.63% | 0.36% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 398.78 K | $7.16 M | -35.83% | 0.36% |
| HIGHVISTA STRATEGIES LLC | 08/14/2026 | 386.08 K | $6.93 M | 9.66% | 0.35% |
| STEMPOINT CAPITAL LP | 08/14/2026 | 384.30 K | $6.90 M | -42.61% | 0.35% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 350.00 K | $6.29 M | -50.00% | 0.31% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 349.44 K | $6.28 M | 100.00% | 0.31% |
Amylyx Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 244 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals Inc. The most heavily invested institutionals were:
EASTERN BANK: 721
FMR LLC: 16.73 M
BlackRock, Inc.: 8.83 M
PERCEPTIVE ADVISORS LLC: 8.33 M
TCG Crossover Management, LLC: 6.24 M
COMMODORE CAPITAL LP: 5.65 M
104.66% of Amylyx Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 131.04 M shares in the last 24 months. This purchase volume represents approximately $1.88 B in transactions.